WALTERS GROUP

ZNTL

WALTERS GROUP serves as 10% Owner at Zentalis Pharmaceuticals, Inc. (ZNTL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$7.75M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$7.75M

Companies Traded

ZNTL

Active Period

Dec 2025

1 total trades

Most Recent

Buy ZNTL

Dec 31, 2025 · $7.75M

WALTERS GROUP's Insider Trading at Zentalis Pharmaceuticals, Inc. (ZNTL)

Buys

1 · $7.75M

Sells

0 · $0.00

Total Shares Bought

6,459,973

Total Shares Sold

ZNTL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 31, 2025	Buy	6,459,973	$1.20	$7.75M	0

Related Insiders

Ingmar Bruns

officer: Chief Medical Officer

ZNTLSell · Feb 10, 2026

EASTLAND JULIA MARIE

director, officer: CEO & President

ZNTLSell · Feb 10, 2026

Vultaggio Vincent

PAO and PFO

ZNTLSell · Feb 10, 2026

Scott Dunseth Myers

Director

ZNTLBuy · Apr 30, 2025

Explore More Insider Trading Data

ZNTL Insider Trading Activity

View all insider trades at Zentalis Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity